Compare ZLAB & SHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZLAB | SHCO |
|---|---|---|
| Founded | 2013 | 1995 |
| Country | China | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 2017 | 2021 |
| Metric | ZLAB | SHCO |
|---|---|---|
| Price | $18.57 | $8.88 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 1 |
| Target Price | ★ $53.52 | $9.00 |
| AVG Volume (30 Days) | 890.5K | ★ 2.0M |
| Earning Date | 02-26-2026 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $441,629,000.00 | ★ $1,288,973,000.00 |
| Revenue This Year | $26.16 | $11.89 |
| Revenue Next Year | $30.62 | $7.87 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 24.14 | 8.48 |
| 52 Week Low | $16.82 | $4.77 |
| 52 Week High | $44.34 | $8.98 |
| Indicator | ZLAB | SHCO |
|---|---|---|
| Relative Strength Index (RSI) | 48.14 | 56.44 |
| Support Level | $18.40 | $7.64 |
| Resistance Level | $19.83 | $7.93 |
| Average True Range (ATR) | 0.56 | 0.17 |
| MACD | 0.26 | -0.01 |
| Stochastic Oscillator | 53.02 | 95.10 |
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.
Soho House & Co Inc is a membership platform of physical and digital spaces that connects a vibrant, diverse group of members from across the world. The members use the platform to work, socialize, connect, create, and flourish all over the world. It offers lease agreements for Houses, hotels, restaurants, studios, spas, and other properties. The company's reportable segments are: United Kingdom; The Americas; and Europe and Rest of the world. The majority of its revenue is generated from the Americas segment, which encompasses its operating units in the Americas, including Soho Houses, stand-alone U.S. restaurants, Soho Friends, and the management fees under a hotel management contract for the operation of The Ned London.